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Abstract 
Background: Advances in long-term parenteral nutrition via indwelling central venous catheter have improved 
the quality of life and mortality in patients with life-threatening gastrointestinal diseases complicated with severely 
impaired absorption. However, infection to central venous catheter is still a common and critical complication for 
such patients. We encountered two patients under long-term parenteral nutrition who developed glomerulonephritis 
associated with central venous catheter infection. Persistent bacterial infection in indwelling medical devices placed 
in the blood-stream such as a ventricular-atrial shunt is known to cause glomerulonephritis, a condition termed shunt 
nephritis. We reported the clinical manifestations, treatment and their pathological findings in the two patients with 
glomerulonephritis associated with central venous catheter infection.
Case presentation: Both patients suffered from megacystis microcolon intestinal hypoperistalsis syndrome, a form 
of pseudo-Hirschsprung’s disease. They had been receiving home parenteral nutrition via central venous catheter 
because of severe malabsorption. They presented proteinuria, hematuria, hypocomplementemia and positive PR3-
antineutrophilic cytoplasmic antibody accompanied by Staphylococcus epidermidis infection in the central venous 
catheter. Their renal biopsy revealed membranoproliferative glomerulonephritis with positive C3 deposition. One of 
them recovered completely following the removal of catheter and administration of antibiotics, while another did not 
respond to the treatments. We then treated her with methylprednisolone pulse therapy followed by prednisolone. 
She responded well, and achieved complete remission.
Conclusion: As central venous catheter infection-related glomerulonephritis has a similar etiology to shunt nephritis, 
removal of the catheter and administration of antibiotics is fundamental to the treatment. If a patient is resistant to 
such conventional therapy, additional steroid and/or immunosuppressive agent could be considered. Although the 
number of patients with classical shunt nephritis is decreasing since the ventricular-peritoneal shunt has become 
became the major procedure for hydrocephalus, central venous catheter infection-related glomerulonephritis may 
increase in the future due to a marked increase in the number of patients receiving long-term parenteral nutrition. 
Routine urinalysis should be considered in such patients for early detection of central venous catheter infection-
related glomerulonephritis.
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Background
Advanced in total parenteral nutrition via central venous 
catheter (CVC) have rescued many patients with con-
genital or acquired life-threatening gastrointestinal dis-
ease broad resection of intestine complicated with severe 
malabsorption, as well as conditions such as short bowel 
syndrome, inflammatory bowel diseases, intractable diar-
rhea and malignancy. In recent years, it is not uncommon 
for patients who are under end-of-life care often receive 
total parenteral nutrition resulting in a rising, number of 
patients receiving long-term home parenteral nutrition 
(HPN). The flip side of HPN, however, is bacterial or fun-
gal infection in indwelling catheter. It is a critical compli-
cation that influences the patient’s mortality.
Glomerulonephritis associated with CVC-related 
infection is a rare complication of long-term total paren-
teral nutrition. Persistent bacterial infection in indwelling 
medical devices in blood-stream, such as ventricular-
atrial shunt (V-A shunt), rarely causes immune-complex-
mediated glomerulonephritis. A representative example 
is shunt nephritis, which occurs in approximately 0.7–
2.3  % of patients with chronic V-A shunt infections 
mainly caused by S. epidermidis, and coagulase-negative 
staphylococcus [1]. Membranoproliferative glomerulone-
phritis with deposits of C3, IgM, and IgG is the most fre-
quent renal pathological finding of shunt nephritis. The 
etiology of CVC infection-related glomerulonephritis 
may be similar to that of shunt nephritis. However, there 
have been few reports of CVC infection-related glomer-
ulonephritis. Here, we describe our encounter with two 




A 12-year-old boy was admitted to our hospital for fur-
ther evaluation of proteinuria, and renal insufficiency. 
He had megacystis microcolon intestinal hypoperistalsis 
syndrome (MMIHS), a form of pseudo-Hirschsprung’s 
disease. He had been on HPN by CVC for 8 years. Two 
months before admission, he presented with macro-
scopic hematuria. He developed proteinuria and renal 
insufficiency 1  month before admission. On admis-
sion, his height was 137.8  cm (−1.49 SD) and body 
weight was 34.2 kg (−0.83 SD). His blood pressure was 
100/54 mmHg, and the chest and abdomen exhibited no 
abnormal findings. Blood examination revealed hypoal-
buminemia (serum albumin of 3.1  g/dL), renal insuf-
ficiency (serum creatinine of 0.68  mg/dL), estimated 
glomerular filtration rate (e-GFR), 70.8 mL/min/1.73 m2, 
hypocomplementemia (C3, 4  mg/dL, C4, 3.4  mg/dL, 
and CH50, 10 U/mL) and positive PR3-anti-neutrophil 
cytoplasmic antibodies (ANCA) (33 U/mL; normal 
range 0–9 U/mL). Urinalysis revealed proteinuria (uri-
nary protein 137.0  mg/dL, urinary creatinine, 63.5  mg/
dL), and hematuria (>100 erythrocytes per high power 
field). Renal biopsy was performed after admission. 
Light microscopy (LM) revealed mesangial prolifera-
tion with one crescent formation in 23–30 glomeruli. 
Immunofluorescence microscopy revealed C3, C1q and 
immunoglobulin (Ig) M deposits along the capillary, and 
in mesangial region. Electron microscopy (EM) revealed 
paramesangial deposits. The pathological findings were 
consistent with membranoproliferative glomerulone-
phritis. We treated him with 60 mg of oral prednisolone 
and 150  mg of mizoribine for 10  days, but his urinary 
findings and renal function did not improve. He sud-
denly developed fever on the 12th day after admission, 
and blood culture did not reveal S. epidermidis (MSSE) 
colonization in the peripheral blood but in the CVC 
instead. We immediately stopped both prednisolone and 
mizoribine, removed the CVC, and administered cefazo-
lin for 10 days.
After the removal of CVC, his renal function gradually 
improved, and proteinuria and hematuria spontaneously 
disappeared in 6 months (Fig. 2a). Recurrence of protein-
uria and hematuria has not been occurred.
Case 2
A 24-year-old woman was admitted to our hospital due 
to fever, hematuria, proteinuria, and renal insufficiency. 
She had suffered from MMIHS, and had been on HPN 
by CVC for 18 years. Three weeks before admission, she 
presented with fever. Two weeks before admission, her 
urine output started to decrease. She developed edema in 
her lower extremities and gained 3 kg in weight.
On admission, her height was 159.4  cm, and 
body weight was 45.8  kg. Her blood pressure was 
110/82 mmHg, and her chest and abdomen exhibited no 
abnormal findings. Blood examination revealed hypoal-
buminemia (serum albumin, 2.5 g/dL), renal insufficiency 
(serum creatinine, 0.92 mg/dL, Cys-C 1.69 mg/L, e-GFR, 
63.1 mL/min/1.73 m2, hypocomplementemia (C3, 57 mg/
dL; C4, 24  mg/dL; and CH50, 10.5  U/mL) and positive 
PR3-ANCA (19  U/mL; normal range 0-9  U/mL). Uri-
nalysis revealed proteinuria (urinary protein 29.1 mg/dL, 
urinary creatinine 18.7  mg/dL), and hematuria (30–49 
erythrocytes per high power field). Blood cultures did not 
reveal S. epidermidis (MRSE) colonization in the periph-
eral blood but in the CVC instead. After admission, we 
immediately removed the CVC and started antibiotics 
for 7  days. Her fever was soon resolved, but proteinu-
ria, hematuria and renal insufficiency continued. Renal 
biopsy was performed 18  days after admission (Fig.  1). 
LM revealed diffuse mesangial proliferation, lobulation 
in the glomeruli, endocapillary proliferation and double 
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contours in the glomerular capillary. Two of 18 glomeruli 
showed global glomerular sclerosis. Immunofluorescence 
microscopy revealed deposits of C3 and IgM with fringe 
pattern along the glomerular capillary. EM revealed sub-
epithelial, subendothelial, and intra-basement membrane 
electron-dense deposits. These biopsy findings are com-
patible with membranoproliferative glomerulonephritis. 
After several blood cultures that proved to be negative, 
she was treated with two courses of methylprednisolone 
pulse therapy followed by 40  mg prednisolone daily for 
1 month. Afterwards, prednisolone was reduced to 40 mg 
every other day and gradually decreased over 8 months. 
She responded well to these treatments, urinary findings 
and renal function completely recovered in 9  months 
(Fig. 2b). She remains free from medication without fur-
ther recurrence of proteinuria and hematuria.
Conclusion
CVC infection-related glomerulonephritis is an immune 
complex-mediated disease accompanied by persistent 
infection of S. epidermidis. Its etiology may be the same 
as that of shunt nephritis.
Shunt nephritis was first reported in 1965 by Black 
et  al. [2] who described two children with nephrotic 
syndrome associated with infection by coagulase-nega-
tive staphylococcus in the V-A shunt. Shunt nephritis is 
often accompanied by hypocomplementemia (89–90  % 
of cases), positive PR3-ANCA, renal insufficiency (50 %), 
and nephritic syndrome (30  %). S. epidermidis infection 
accounts for 75 % of all shunt nephritis cases [1, 3]. While 
over half of the individuals with shunt nephritis achieved 
complete recovery, 40  % developed persistent urine 
abnormalities or end-stage renal disease (ESRD), and 9 % 
experienced death [1]. Wyatt et al. [5] reported the serial 
complement profile in patients with shunt nephritis. A 
decrease in the serum levels of C1q, C3 and C4 due to 
activation of classical pathway occurred, but, was resolved 
after treatment. The two patients in our case showed com-
patible clinical manifestations and laboratory findings, 
suggesting a similar etiology. Previously, Kusaba et al. [5] 
had also speculated that the classical complement path-
way might be involved in CVC infection-related glomer-
ulonephritis because immunofluorescence microscopy 
revealed C3 and IgM deposits and hypocomplementemia 
disappeared after catheter removal.
Although, staphylococcus infection-associated glo-
merulonephritis and lupus nephritis are given in differen-
tial diagnosis, CVC infection-related glomerulonephritis 
revealed a different pattern of immunofluorescent stain-
ing. Furthermore, PR-3 ANCA often becomes positive 
while anti-dsDNA antibody is negative in CVC infection-
related glomerulonephritis.
In the previous literatures, there were only four patients 
with CVC infection-related glomerulonephritis [5–7]. All 
Fig. 1 First biopsy of patient 2: a (PAS stain, magnification ×400); b (PAM stain, magnification ×400), mesangial proliferation, increased lobulation, 
doubled contours: c (electron microscopy), subepithelial, subendothelial, mesangial deposit: d (immuno-fluorescence microscopy), C3 (++), IgM 
(++), C1q (+), IgG (+) fringe pattern
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of them had abnormal urinary findings, renal impairment 
and hypocomplementemia that improved after CV cath-
eter removal, except one who developed ESRD. Among 
them, the details of two patients were not described 
[7]. Therefore, we have included the details of these two 
patients together with those of our patients in Table 1.
Our patients showed positive PR3-ANCA. Although 
the underlying mechanism for positive PR3-ANCA 
is unclear, a likely explanation is that when patho-
gens destroy neutrophils, PR-3 antigen may become 
exposed on the surface and results in the produc-
tion of PR3-ANCA. Indeed, PR3-ANCA is positive 
not only in patients with vasculitis, but also in those 
with infections such as Streptococcus infection [8] 
and HIV [9]. PR3-ANCA was transiently positive in 
33  % of patients with septic shock [10]. In our cases, 
Fig. 2 a Clinical course of patient 1, b clinical course of patient 2
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PR3-ANCA became negative after the resolution of 
glomerulonephritis.
Most patients with CVC infection-related glomeru-
lonephritis responded well to catheter removal and 
administration of antibiotics. However, Kusaba et al. [5] 
reported a 59-year-old woman with glomerulonephritis 
developed ESRD because catheter removal was delayed. 
The timing of CVC removal is difficult. The Clinical 
Practice Guidelines for the Diagnosis and Manage-
ment of Intravascular Catheter-Related Infection 2009 
by the Infectious Diseases Society of America proposed 
that in principal the treatment of CVC infection due to 
coagulase-negative staphylococci is CVC removal and 
administration of antibiotics for 5–7  days. However, 
when CVC removal is not possible, antibiotics admin-
istration and antibiotic lock therapy should be contin-
ued for 10–14  days. In the patient reported by Kusaba 
et  al., inflammatory parameters improved after admin-
istration of antibiotics. However, hypocomplementemia 
persisted until removal of the CVC, with ESRD even-
tually developing. This suggested that administration 
of antibiotics alone was insufficient. Therefore, early 
detection, prompt catheter removal and treatment 
with antibiotics are essential the same treatment strat-
egy against shunt nephritis. Although patient 2 did not 
respond to catheter removal and administration of anti-
biotics, steroid therapy was effective. In spite of Patient 
2 having MRSE colonization, we administered cefazo-
line for 7 days. While it might contribute to continuous 
proteinuria, hematuria, and renal insufficiency, it was 
unlikely that catheter-related blood stream infection 
continued because the patient’s fever dropped immedi-
ately and blood culture was negative after the removal 
of the CVC. Steroids should be administered carefully 
to patients who have infectious disease. We treated 
patient 1 with steroids and mizoribine before admin-
istration of antibiotics because we did not notice his 
catheter infection until he developed fever. Therefore, 
we stopped administration of steroids and mizoribine 
when blood culture revealed MSSE colonization. In the 
event that several sets of blood cultures proved negative 
after the removal of infected catheter, additional treat-
ment with steroid and/or immunosuppressive agent can 
be considered based on the pathogenesis. Similarly, effi-
cacy of steroid against refractory shunt nephritis after 
replacement of the V-A shunt has been reported [11]. 
At present, the dose of prednisolone is not fixed now. 
Iwata et al. [11] initiated oral prednisolone at a dose of 
50  mg/day after replacement of shunt. In our case, we 
used a dose of prednisolone based on the guideline for 
IgA nephritis.
There is a possibility that the severity of underlying dis-
ease is involved in the outcome. To date, however there 
are have been no reports of patients diagnosed with renal 
insufficiency before CVC infection in previous reports. 
Therefore, early detection and treatment are the most 
crucial to improve prognosis.
Although the numbers of patients with shunt nephri-
tis is decreasing because ventricular-peritoneal shunt has 
become the major procedure for hydrocephalus (instead 
of V-A shunt), cases of CVC infection-related glomeru-
lonephritis may increase because more patients will be 
treated with long-term parenteral nutrition. Meanwhile, 
some patients with CVC infection-related glomerulo-
nephritis may be overlooked because of mild or chronic 
manifestation or spontaneous recovery by removal of the 
Table 1 CVC infection-related glomerulonephritis in published reports and our patients
MMIHS megacystis microcolon intestinal hypoperistasis syndrome, CVC central venous catheter, CCr creatinine clearance, e-GFR estimated glomerular filtration rate, 
GN glomerulonephritis, MPGN membranoproliferative glomerulonephritis, MPT methyl prednisolone pulse therapy, PSL prednisolone, ESRD end stage renal disease
Ohara et al. Kusaba et al. Patient 1 Patient 2
Age, sex 13, M 59, F 12, M 24, F
Underlying disease Short bowel syndrome Post-radiation enteritis MMIHS MMIHS
Duration of CVC (years) 13 2 8 18
Blood culture S. epidermidis S. epidermidis S. epidermidis (MSSE) S. epidermidis (MRSE)
24 h CCr/e-GFR (mL/
min/1.73 m2)
84.6/− −/5.3 77.4/70.8 −/63.1
C3/C4/CH50 30/8/ <10 30/10/ <12 69/7.4/26.4 57/24/10.5
PR3-ANCA N/D <5 33 19
Renal pathology (positive IF) MPGN C3, IgM, C1 Crescentic GN C3, IgM, IgG MPGN C3, IgM, C1q MPGN C3, IgM
Treatment CVC removal CVC removal CVC removal CVC removal
Cefazolin for 10 days Cefazolin (3 g/day) for 10 days Cefazolin (3 g/day) for 7 days
PSL 60 mg/day + MZR 150 mg/
day for 10 days
MPT 2 courses + PSL 40 mg/
day for 1 month
Outcome Full recovery ESRD Full recovery Full recovery
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CVC at the time of the infection. However, to prevent a 
delay in detection, routine urinalysis is recommended 
in patients receiving long-term parenteral nutrition via 
indwelling CVC.
Consent
Written informed consent was obtained from the patient 
or patient’s parents for publication of this case report and 
any accompanying images.
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